Celanese Options Market Sees Large Bet on October 2026 Rally

A single, large options trade on Celanese Corp. (CE) dominated Tuesday's session, suggesting a sophisticated bet on a share price increase in a specific one-month window in late 2026. The transaction, a call calendar spread, involved 5,019 contracts on each leg and represented 98.5% of the chemical company's total options volume for the day, according to market data.

The Anatomy of the Trade

The trade was structured as a call calendar spread targeting the $50 strike price, a level approximately 8.7% above Celanese's current share price of $46.00. The specific legs of the trade were:

• Selling 5,019 call options with a September 18, 2026, expiration.
• Buying 5,019 call options with an October 16, 2026, expiration.

This strategy implies a belief that Celanese shares will remain below $50 through the September expiry, allowing the sold calls to expire worthless. The core of the bet is on the long October calls, positioning for a rally toward or through the $50 level within the 28-day period before the October expiration.

Analysis of open interest supports this view. The purchased October calls represent a nearly new position, with existing open interest at just 309 contracts. Conversely, the sold September calls added to a substantial existing position of 6,613 contracts, suggesting the $50 level has been a point of focus for traders.

Potential Catalysts on the Horizon

Ad

The specific timing of the trade appears linked to potential market-moving events for Celanese. The company's third-quarter 2026 earnings report would typically be released within that October window.

Beyond earnings, the trade could be anticipating news related to the company's deleveraging strategy. Management has previously guided for the sale of its Nutrinova stake to Mitsui to close in Q4 2026, with proceeds earmarked for debt reduction. Any acceleration of that timeline or news of other asset sales, part of a plan to divest $1 billion by the end of 2027, could serve as a catalyst for the stock.

Market and Volatility Context

The options market is pricing in significant uncertainty for the industrial chemical firm, with 3-month implied volatility at an elevated 50.15%. This reflects ongoing investor focus on the company's debt load.

However, a drop in volatility on the day of the trade lowered the cost of purchasing the long-dated October calls. The stock remains well below its 52-week high of $70.70, but the $50 strike represents a notable hurdle that has previously acted as a resistance level.